Noise in multiple sclerosis: unwanted and necessary

Annals of Clinical and Translational Neurology

Volumn 1, Issue 7, 2014, Pages 502-511

  Bordi, Isabella ^a   Ricigliano, Vito A G ^b,c   Umeton, Renato ^b   Ristori, Giovanni ^b   Grassi, Francesca ^a   Crisanti, Andrea ^a   Sutera, Alfonso ^a   Salvetti, Marco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; MESSENGER RNA; MICRORNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; TRANSCRIPTION FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HELPER CELL; HUMAN; HYPERTENSION; LYMPHOCYTE DIFFERENTIATION; MULTIFACTORIAL GENETIC DISORDER; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 85014871052     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.72     Document Type: Article

References (82)

1. Eichler EE, Flint J, Gibson G, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010;11:446–450.
2. Sawcer S, Ban M, Wason J, Dudbridge F. What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010;67:3–10.
3. D'Netto MJ, Ward H, Morrison KM, et al. Risk alleles for multiple sclerosis in multiplex families. Neurology 2009;72:1984–1988.
4. Gourraud PA, McElroy JP, Caillier SJ, et al. Aggregation of multiple sclerosis genetic risk variants in multiple sclerosis and single case families. Ann Neurol 2010;69:65–74.
5. Hardy J, Thompson AJ. Dissecting the familial risk of multiple sclerosis. Ann Neurol 2010;69:11–12.
6. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet 2012;13:135–145.
7. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA 2012;109:1193–1198.
8. Sawcer S, Wason J. Risk in complex genetics: “All models are wrong but some are useful”. Ann Neurol 2012;72:502–509.
9. Tennessen JA, Bigham AW, O'Connor TD, et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012;337:64–69.
10. Hunt KA, Mistry V, Bockett NA, et al. Negligible impact of rare autoimmune-locus coding- region variants on missing heritability. Nature 2013;498:232–237.
11. Taylor BV. The major cause of multiple sclerosis is environmental: genetics has a minor role-yes. Mult Scler 2011;17:1171–1173.
12. Sawcer S. The major cause of multiple sclerosis is environmental: genetics has a minor role- no. Mult Scler 2011;17:1174–1175.
13. Hutchinson M. The major cause of multiple sclerosis is environmental: genetics has a minor role-commentary. Mult Scler 2011;17:1176.
14. Ricigliano VAG, Umeton R, Germinario L, et al. Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact. PLoS One 2013;8:e71198.
15. Ebers GC. A twin consensus in MS. Mult Scler 2005;11:497–499.
16. Box GEP, Jenkins GM. Time series analysis: forecasting and control. San Francisco, CA: Holden-Day, 1970.
17. Sutera A. On stochastic perturbation and long-term climate behaviour. Q J R Meteorol Soc 1981;107:137–151.
18. Benzi R, Parisi G, Sutera A, Vulpiani A. A theory of stochastic resonance in climatic change. SIAM J Appl Math 1983;43:565–578.
19. Bordi I, Sutera A. Stochastic perturbation in meteorology. Wave Random Media 2000;10:1–30.
20. Brandes M, Klauschen F, Kuchen S, Germain RN. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 2013;154:197–212.
21. Hauser SL, Chan JR, Oksenberg JR. Multiple sclerosis: prospects and promise. Ann Neurol 2013;74:317–327.
22. Ascherio A, Munger KLM, Lünemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012;8:602–612.
23. Mechelli R, Umeton R, Policano C, et al. A “candidate-interactome” aggregate analysis of genome-wide association data in multiple sclerosis. PLoS One 2013;8:e63300.
24. Raj A, van Oudenaarden A. Nature, nurture or chance: stochastic gene expression and its consequences. Cell 2008;135:216–226.
25. Eldar A, Elowitz MB. Functional role for noise in genetic circuits. Nature 2010;467:167–173.
26. Frigola D, Casanellas L, Sanch JM, Ibañes M. Asymmetric stochastic switching driven by intrinsic molecular noise. PLoS One 2012;7:e31487.
27. Weber M, Buceta J. Stochastic stabilization of phenotypic states: the genetic bistable switch as a case study. PLoS One 2013;8:e73487.
28. Stewart-Ornstein J, Weissman JS, El-Samad H. Cellular noise regulons underlie fluctuations in Saccharomyces cerevisiae. Mol Cell 2012;45:483–493.
29. Sigal A, Milo R, Cohen A, et al. Variability and memory of protein levels in human cells. Nature 2006;444:643–646.
30. Heng HH. Missing heritability and stochastic genome alterations. Nat Rev Genet 2010;11:813.
31. Novick A, Weiner M. Enzyme production as an all-or-none phenomenon. Proc Natl Acad Sci USA 1957;43:553–566.
32. McAdams HH, Arkin A. Stochastic mechanisms in gene expression. Proc Natl Acad Sci USA 1997;94:814–819.
33. Czyz W, Morahan JM, Ebers GC, Ramagopalan SV. Genetic, environmental and stochastic factors in monozygotic twins discordance with a focus on epigenetic differences. BMC Med 2012;10:93.
34. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007;130:25–35.
35. Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011;365:1612–1623.
36. Lebrun C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol 2009;66:841–846.
37. Chard DT, Dalton CM, Swanton J, et al. MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2011;82:176–179.
38. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502–1517.
39. McLeod JG, Hammond SR, Kurtzke JF. Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration. J Neurol 2011;258:1140–1149.
40. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 2010;6:156–166.
41. Bordi I, Umeton R, Ricigliano VAG, et al. A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis. Int J Genomics 2013;2013:910321.
42. Munski B, Nevert G, van Oudenaarden A. Using gene expression noise to understand gene regulation. Science 2012;336:183–187.
43. Raj A, Peskin CS, Tranchina D, et al. Stochastic mRNA synthesis in mammalian cells. PLoS Biol 2006;4:e309.
44. Raj A, Rifkin SA, Andersen E, van Oudenaarden A. Variability in gene expression underlies incomplete penetrance. Nature 2010;463:913–918.
45. Dalerba P, Kalisky T, Sahoo D, et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 2011;29:1120–1127.
46. Itzkovitz S, Lyubimova A, Blat IC, et al. Single-molecule transcript counting of stem-cell markers in the mouse intestine. Nat Cell Biol 2012;14:106–115.
47. Hansen CH, van Oudenaarden A. Allele-specific detection of single mRNA molecules in situ. Nat Methods 2013;10:869–871.
48. Shalek AK, Satija R, Adiconis X, et al. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 2013;498:236–240.
49. Wills QF, Livak KJ, Tipping AJ, et al. Single-cell gene expression analysis reveals genetic associations masked in whole-tissue experiments. Nat Biotechnol 2013;31:748–752.
50. Zhu L, Zhang W, Elnatan D, Huang B. Faster STORM using compressed sensing. Nat Methods 2012;9:721–723.
51. Buganim Y, Faddah DA, Cheng AW, et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and late hierarchic phase. Cell 2012;150:1209–1222.
52. Bhatt DM, Pandya-Jones A, Tong AJ, et al. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 2012;150:279–290.
53. Little SC, Wieschaus EF. Shifting patterns: merging molecules, morphogens, motility and methodology. Dev Cell 2011;21:2–4.
54. Sawarkar R, Sievers C, Paro R. Hsp90 globally targets paused RNA polymerase to regulate gene expression in response to environmental stimuli. Cell 2012;149:807–818.
55. Zhang Q, Bhattacharya S, Andersen ME. Ultrasensitive response motifs: basic amplifiers in molecular signalling networks. Open Biol 2013;3:130031.
56. de Krom M, von Lindem M, Grosveld F, Strouboulis J. Stochastic patterns in globin gene expression are established prior to transcriptional activation and are clonally inherited. Mol Cell 2002;9:1319–1326.
57. Hathaway NA, Bell O, Hodges C, et al. Dynamics and memory of heterochromatin in living cells. Cell 2012;149:1447–1460.
58. Zhu J, Adli M, Zou JY, et al. Genome-wide chromatin state transitions associated with developmental and environmental clues. Cell 2013;152:642–654.
59. Disanto G, Sandve GK, Berlanga-Taylor AJ, et al. Genomic regions associated with multiple sclerosis are active in B cells. PLoS One 2012;7:e3228.
60. Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease- associated variation in regulatory DNA. Science 2012;337:1190–1195.
61. De Jager PL, Bennett DA. An inflection point in gene discovery efforts for neurodegenerative diseases: from syndromic diagnoses toward endophenotypes and the epigenome. JAMA Neurol 2013;70:719–726.
62. Menon R, Di Dario M, Cordiglieri C, et al. Gender-based blood transcritptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J Autoimmun 2011;38:144–155.
63. Disanto G, Sandve GK, Berlanga-Taylor AJ, et al. Vitamin D receptor binding, chromatin states and association with multiple sclerosis. Hum Mol Genet 2012;21:3575–3586.
64. Ho Y-C, Shan L, Hosmane NN, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 2013;155:540–551.
65. Arvey A, Tempera I, Tsai K, et al. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe 2012;12:233–245.
66. Arvey A, Tempera I, Lieberman PM. Interpreting the Epstein-Barr virus (EBV) epigenome using high-throughput data. Viruses 2013;5:1042–1054.
67. Teng MW, Bolovan-Fritts C, Dar RD, et al. An endogenous accelerator of viral gene expression confers a fitness advantage. Cell 2012;151:1569–1580.
68. Lovén J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013;153:320–334.
69. Klein G, Klein E, Kashuba E. Interaction of Epstein-Barr virus (EBV) with human B- lymphocytes. Biochem Biophys Res Commun 2010;396:67–73.
70. Lin CY, Lovén J, Rahl PB, et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012;151:56–67.
71. Nie Z, Hu G, Wei G, et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012;151:68–79.
72. Faroudi M, Utzny C, Salio M, et al. Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold. Proc Natl Acad Sci USA 2003;100:14145–14150.
73. Fang M, Xie H, Dougan SK, et al. Stochastic cytokine expression induces mixed T helper cell states. PLoS Biol 2013;11:e1001618.
74. Ristori G, Salvetti M, Pesole G, et al. Compositional bias and mimicry toward the nonself proteome in immunodominant T cell epitopes of self and nonself antigens. FASEB J 2000;14:431–438.
75. Di Zenzo G, Di Lullo G, Corti D, et al. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. J Clin Invest 2012;122:3781–3790.
76. Ristori G, Buzzi MG, Sabatini U, et al. Use of Bacille Calmette Guèrin (BCG) in multiple sclerosis. Neurology 1999;53:1588–1589.
77. Ristori G, Romano S, Cannoni S, et al. Effects of Bacille Calmette-Guèrin after the first demyelinating event in the CNS. Neurology 2014;82:41–48.
78. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013;496:518–522.
79. Paling D, Solanky BS, Riemer F, et al. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. Brain 2013;136:2305–2317.
80. Maccarrone M, Bernardi G, Agrò AF, Centonze D. Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance. Br J Pharmacol 2011;163:1379–1390.
81. De Jager PL, Chibnik LB, Cui J, et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol 2009;8:1111–1119.
82. Sejdic E, Lipsitz LA. Necessity of noise in physiology and medicine. Comput Methods Programs Biomed 2013;111:459–470.